In contrast to breast cancer cells in in vitro culture, the expression of CHI3L2 in tumors was highest in tumors positive for estrogen receptor (ER) and progesterone receptor (PR) and lowest in HER2 positive tumors. This evidence concerns the gene PGR and breast cancer.